Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
HomeProduct name listCisapride

Cisapride

Synonym(s):cis-4-Amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenxamide monohydrate;Acenalin;Cipril;Cisapride monohydrate

  • CAS NO.:81098-60-4
  • Empirical Formula: C23H29ClFN3O4
  • Molecular Weight: 465.95
  • MDL number: MFCD03305346
  • EINECS: 279-689-7
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2023-06-30 15:45:59
Cisapride Structural

What is Cisapride?

Absorption

Cisapride is rapidly absorbed after oral administration, with an absolute bioavailability of 35-40%.

Description

Cisapride is a gastroprokinetic useful in the treatment of reflux esophagitis, constipation, and a variety of gastro-intestinal motility disorders. Its novel mechanism of action is thought to involve the enhancement of acetylcholine release in the mysenteric plexus of the gut. It is reportedly devoid of CNS and cardiac side-effects.

The Uses of Cisapride

Cisapride Monohydrate is a cardioactive drug that causes prolongation of cardiac repolarization in human; selective serotonin 5-HT4 receptor agonist.

Indications

For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease.

Background

In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias. The FDA issued a warning letter regarding this risk to health care professionals and patients.

What are the applications of Application

Cisapride is a SR-4 agonist also known as Enteropride

Pharmacokinetics

Cisapride is a parasympathomimetic which acts as a serotonin 5-HT4 agonist; upon activation of the receptor signaling pathway, cisapride promotes the release of acetylcholine neurotransmitters in the enteric nervous system. Cisapride stimulates motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. Cisapride increases the tone and amplitude of gastric (especially antral) contractions, relaxes the pyloric sphincter and the duodenal bulb, and increases peristalsis of the duodenum and jejunum resulting in accelerated gastric emptying and intestinal transit. It increases the resting tone of the lower esophageal sphincter. It has little, if any, effect on the motility of the colon or gallbladder. Cisapride does not induce muscarinic or nicotinic receptor stimulation, nor does it inhibit acetylcholinesterase activity.

Metabolism

Hepatic. Extensively metabolized via cytochrome P450 3A4 enzyme.

Properties of Cisapride

Melting point: 109.8 °C
Boiling point: 605.4±55.0 °C(Predicted)
Density  1.29±0.1 g/cm3(Predicted)
storage temp.  Keep in dark place,Inert atmosphere,Room temperature
solubility  DMSO: ~30 mg/mL
form  solid
color  white
Water Solubility  9.319mg/L(30 ºC)

Safety information for Cisapride

Computed Descriptors for Cisapride

Related products of tetrahydrofuran

You may like

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.